Vorasidenib-VORANIGO’s latest bottle price and price comparison across different channels

Vorasidenib (trade name VORANIGO) is a new oral small molecule targeted drug, mainly used to treat IDH1/2 mutated low-grade gliomas and some advanced brain tumors. This drug inhibits the activity of IDH mutant enzyme and reduces the accumulation of 2-hydroxyglutarate (2-HG) in tumor cells, thereby inhibiting tumor growth and malignant transformation. Although its efficacy has been verified in clinical trials, vorsidenib is not yet on the market in China, nor is it included in the medical insurance system, so domestic patients are temporarily unable to purchase it through formal channels.

In overseas markets, the specifications of the US version of original research Voxanib are40mg*30 tablets, with a price of more than 380,000 yuan per box. As prices are affected by factors such as exchange rates, taxes, and shipping costs, the actual purchase cost may fluctuate. The high price of original drugs means that patients must fully consider their affordability when using them and develop individualized treatment plans under the guidance of doctors.

At the same time, generic versions of Voxanib have also appeared in overseas markets. Taking the Laos market as an example, each box of Voxanib of the same specifications produced by Lucius Pharmaceuticals sells for about more than 7,000 yuan. The ingredients of generic drugs are basically the same as those of original drugs, which can provide patients with a more economical choice, but they still need to be purchased through formal channels to ensure drug quality and safety.

Overall, Voxanib has not yet been launched in China, and price references mainly come from overseas markets. Original drugs are expensive, while generic drugs are cheap, providing a viable alternative for patients with limited financial conditions. When choosing drug purchase channels, patients should comprehensively consider drug accessibility, price, legality and doctor's advice to ensure continuity of treatment and safety of medication.

Reference materials:https://www.drugs.com/